Color Genomics leverages advanced technologies to provide comprehensive cancer care and support. As the first fully-integrated Virtual Cancer Clinic in the U.S., Color offers on-demand cancer care through physician-led teams that ensure timely screenings, accurate diagnostics, and effective treatment plans. Their approach emphasizes early intervention, which is crucial for improving patient outcomes by addressing high-risk factors before they escalate into more significant health issues. Additionally, Color's partnership with the American Cancer Society enhances access to screenings and support, making cancer care more convenient and compassionate for patients.

In the realm of research and genetic testing, Color operates a state-of-the-art CLIA-certified and CAP-accredited laboratory that specializes in clinical and research-grade genome sequencing. Their user-centric digital engagement platform facilitates participant recruitment and longitudinal engagement, while advanced bioinformatics and machine learning tools enable the processing of vast amounts of genomic data to identify significant associations. This comprehensive infrastructure not only supports population health research but also ensures that participants receive tailored health information and access to genetic counseling, ultimately contributing to better health outcomes and informed community health solutions.

United States

Genetic testing, direct to consumerCOVID-19: EUA (05/2020) for their LAMP (Loop-mediated amplification) and uses three SARS-CoV-2-specific primer sets targeting the SARS-CoV-2 nucleocapsid gene (N), the envelope gene (E), and the ORF1a region.

Color Genomics

Company Details